MD Anderson Cancer Center Site Number : 8400013

Houston, Texas 77030-4000

0 studies enrolling now · 1 studies all time

What they study most

Plasma Cell Myeloma

Studies at this site

• A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) — Completed